Metraipolis › archive › dc_b895200ab331

Modulating alternative splicing of MECP2 is a potential therapeutic strategy for Rett syndrome — Europe PMC PMID:41779872

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41779872
DOI
10.1126/scitranslmed.adq4529
License (as archived)
solo-consultazione
Archived
2026-11-05T04:09:29.791Z
SHA-256 of the archived text
9b160a86b9c5235ff7a4873c2a00b8cb95728cdf4e571f2a59b79e5c5f132e58
Stable URL of this page
https://metraipolis.com/documento/dc_b895200ab331

How to cite

Modulating alternative splicing of MECP2 is a potential therapeutic strategy for Rett syndrome — Europe PMC PMID:41779872 — Europe PMC (en), https://europepmc.org/article/MED/41779872 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b895200ab331 (Metraipolis archive dc_b895200ab331, sha256 9b160a86b9c5235ff7a4873c2a00b8cb95728cdf4e571f2a59b79e5c5f132e58)
BibTeX
@misc{dcb895200ab331,
  title = {Modulating alternative splicing of MECP2 is a potential therapeutic strategy for Rett syndrome — Europe PMC PMID:41779872},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41779872},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b895200ab331; sha256 9b160a86b9c5235ff7a4873c2a00b8cb95728cdf4e571f2a59b79e5c5f132e58},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41779872. Agents can read the archived copy with the MCP tool read_document.